An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage

Newman, Aaron M, Bratman, Scott V, To, Jacqueline, Wynne, Jacob F, Eclov, Neville C W, Modlin, Leslie A, Liu, Chih Long, Neal, Joel W +6 more·2014·Nature Medicine

Cited by (1,002)

Items 601–700 of 1,002

  1. Optimizing Nanopore sequencing-based detection of structural variants enables individualized circulating tumor DNA-based disease monitoring in cancer patients
    Jose Espejo Valle-Inclán, Christina Stangl, Anouk C. de Jong, Lisanne F. van Dessel, Markus J. van Roosmalen, Jean Helmijr, Ivo Renkens, Roel Janssen, Sam de Blank, Chris J. de Witte et al. · 2021 · Genome Medicine
  2. Accurate detection of circulating tumor DNA using nanopore consensus sequencing
    Alessio Marcozzi, Myrthe Jager, Martin Elferink, Roy Straver, Joost H. van Ginkel, Boris Peltenburg, Li‐Ting Chen, Ivo Renkens, Joyce van Kuik, Chris H.J. Terhaard et al. · 2021 · npj Genomic Medicine
  3. EGFR T790M: revealing the secrets of a gatekeeper
    Brian Ko, Daniel Paucar, Balázs Halmos · 2017 · Lung Cancer Targets and Therapy
  4. Blood-based biomarkers in lung cancer: prognosis and treatment decisions
    Meng Xu‐Welliver, David Paul Carbone · 2017 · Translational Lung Cancer Research
  5. Deactivated CRISPR Associated Protein 9 for Minor-Allele Enrichment in Cell-Free DNA
    Amin Aalipour, Jonathan C. Dudley, Seung-min Park, Surya Murty, Jacob J. Chabon, Evan A. Boyle, Maximilian Diehn, Sanjiv Sam Gambhir · 2017 · Clinical Chemistry
  6. Extending Circulating Tumor DNA Analysis to Ultralow Abundance Mutations: Techniques and Challenges
    Andrew E. Rodda, Bradyn J. Parker, Andrew G Spencer, Simon R. Corrie · 2018 · ACS Sensors
  7. Thermodynamics and kinetics guided probe design for uniformly sensitive and specific DNA hybridization without optimization
    Xin Chen, Na Liu, Liquan Liu, Wei Chen, Na Chen, Meng Lin, Jia-Ju Xu, Xing Zhou, Hongbo Wang, Mei-Ping Zhao et al. · 2019 · Nature Communications
  8. Liquid Biopsy: The Unique Test for Chasing the Genetics of Solid Tumors
    Seyed Mohammad Kazem Aghamir, Ramin Heshmat, Mehdi Ebrahimi, Fatemeh Khatami · 2020 · Epigenetics Insights
  9. Ultra-sensitive detection of tumor-specific mutations in saliva of patients with oral cavity squamous cell carcinoma
    Ashwini Shanmugam, A. Hariharan, R. Hasina, J. Nair, S. Katragadda, Sivaraj Irusappan, A. Ravichandran, V. Veeramachaneni, Radhakrishna Bettadapura, Muddasir Bhati et al. · 2020 · Cancer
  10. High sensitivity automated multiplexed immunoassays using photonic crystal enhanced fluorescence microfluidic system
    Yafang Tan, Tiantian Tang, Haisheng Xu, Chenqi Zhu, Brian T. Cunningham · 2015 · Biosensors and Bioelectronics
  11. Liquid biopsies for residual disease and recurrence
    Jonathan C. M. Wan, Tariq I. Mughal, Pedram Razavi, Sarah‐Jane Dawson, Esther Louise Moss, Ramaswamy Govindan, Iain Beehuat Tan, Yoon Sim Yap, William Allen Robinson, Clive Dylan Morris et al. · 2021 · Med
  12. Polyanions in Coagulation and Thrombosis: Focus on Polyphosphate and Neutrophils Extracellular Traps
    Chandini Rangaswamy, Hanna Englert, Carsten Deppermann, Thomas Renné · 2020 · Thrombosis and Haemostasis
  13. Circulating tumor DNA to guide diagnosis and treatment of localized and locally advanced non-small cell lung cancer
    Arianna Marinello, Marco Tagliamento, Arianna Pagliaro, Nicole Conci, Eugenia Cella, Damien Vasseur, Jordi Remón, Antonin Lévy, Filippo Gustavo Dall’Olio, Benjamin Besse · 2024 · Cancer Treatment Reviews
  14. Robust Detection of DNA Hypermethylation of ZNF154 as a Pan-Cancer Locus with in Silico Modeling for Blood-Based Diagnostic Development
    Gennady Margolin, Hanna M. Petrykowska, Nader Jameel, Daphne W. Bell, Alice Young, Laura L. Elnitski · 2016 · Journal of Molecular Diagnostics
  15. The Role of Next‐Generation Sequencing in Enabling Personalized Oncology Therapy
    CA Cummings, Eric J Peters, Ludovic Lacroix, Fabrice André, MR Lackner · 2016 · Clinical and Translational Science
  16. Circulating tumor cells and circulating tumor DNA: What surgical oncologists need to know?
    Luc Cabel, Charlotte Proudhon, Pascale Mariani, Dimitri Tzanis, Guillaume Beinse, Ivan Bièche, Jean‐Yves Pierga, François‐Clément Bidard · 2017 · European Journal of Surgical Oncology
  17. Cell-Free DNA in Oncology: Gearing up for Clinic
    Bryan C. Ulrich, Cloud Peter Paweletz · 2017 · Annals of Laboratory Medicine
  18. Circulating Tumor DNA for Early Cancer Detection
    Clare Fiala, Vathany Kulasingam, Eleftherios P. Diamandis · 2018 · The Journal of Applied Laboratory Medicine
  19. Ultra-Short Circulating Tumor DNA (usctDNA) in Plasma and Saliva of Non-Small Cell Lung Cancer (NSCLC) Patients
    Feng Li, Wei Fang, Wei-Lun Huang, Chien‐Chung Lin, Liang Li, Macy Shen, Qingxiang Yan, Wei Liao, David Chia, Michael Kai Tu et al. · 2020 · Cancers
  20. Decoding the Evolutionary Response to Ensartinib in Patients With ALK-Positive NSCLC by Dynamic Circulating Tumor DNA Sequencing
    Yunpeng Yang, Jie Huang, Tao Wang, Jianya Zhou, Jing Zheng, Jifeng Feng, Wu Zhuang, Jianhua Chen, Jun Zhao, Wei Zhong et al. · 2021 · Journal of Thoracic Oncology
  21. Preclinical models and technologies to advance nanovaccine development
    Carina Peres, Ana I. Matos, Liane I.F. Moura, Rita C. Acúrcio, Bárbara Carreira, Sabina Pozzi, Daniella Vaskovich‐Koubi, Ron Kleiner, Ronit Satchi‐Fainaro, Helena F. Florindo · 2021 · Advanced Drug Delivery Reviews
  22. Sensitivity, specificity, and accuracy of a liquid biopsy approach utilizing molecular amplification pools
    Jessica Garcia, Nick Kamps‐Hughes, Florence Geiguer, S. Couraud, Brice A. J. Sarver, Lea Francoise Payen, Cristian Ionescu‐Zanetti · 2021 · Scientific Reports
  23. Diving into the Pleural Fluid: Liquid Biopsy for Metastatic Malignant Pleural Effusions
    Maria Alba Sorolla, Anabel Sorolla, Eva Parisi, Antonieta Salud, José Manuel Porcel · 2021 · Cancers
  24. Early diagnosis of lung cancer using magnetic nanoparticles-integrated systems
    Ayushi Rastogi, Kanchan Yadav, Archana Mishra, Manu Smriti Singh, Shilpi Chaudhary, Rajiv Manohar, Avanish Singh Parmar · 2022 · Nanotechnology Reviews
  25. Circulating Tumor DNA Analyses as a Potential Marker of Recurrence and Effectiveness of Adjuvant Chemotherapy for Resected Non-Small-Cell Lung Cancer
    Peng‐Peng Kuang, Ning Li, Zui Liu, Tianyu Sun, Shu-Quan Wang, Jia Hu, Wei Ou, Si-Yu Wang · 2021 · Frontiers in Oncology
  26. A Noninvasive Multianalytical Approach for Lung Cancer Diagnosis of Patients with Pulmonary Nodules
    Quanxing Liu, Dong Zhou, Tiancheng Han, Xiao Lu, Bing Hou, Manyuan Li, Guixue Yang, Qingyuan Li, Zhihua Pei, Yuanyuan Hong et al. · 2021 · Advanced Science
  27. Tumor-Informed Approach Improved ctDNA Detection Rate in Resected Pancreatic Cancer
    Kazunori Watanabe, Toru Nakamura, Yasutoshi Kimura, Masayo Motoya, Shigeyuki Kojima, Tomotaka Kuraya, Takeshi Murakami, Tsukasa Kaneko, Yoshihito Shinohara, Yosuke Kitayama et al. · 2022 · International Journal of Molecular Sciences
  28. Advances in Liquid Biopsy Technology and Implications for Pancreatic Cancer
    Alexander Grenander Raufi, Michael S. May, Matthew James Hadfield, Attila A. Seyhan, Wafik S. El‐Deiry · 2023 · International Journal of Molecular Sciences
  29. The changing face of circulating tumor DNA (ctDNA) profiling: Factors that shape the landscape of methodologies, technologies, and commercialization
    Abel Jacobus Bronkhorst, Stefan Holdenrieder · 2023 · Medizinische Genetik
  30. Detecting cancer biomarkers in blood: challenges for new molecular diagnostic and point-of-care tests using cell-free nucleic acids
    Jean M. Lewis, Daniel P. Heineck, Michael J. Heller · 2015 · Expert Review of Molecular Diagnostics
  31. Fluorogenic Templated Reaction Cascades for RNA Detection
    Willem A. Velema, Eric T. Kool · 2017 · Journal of the American Chemical Society
  32. Perspective on immune oncology with liquid biopsy, peripheral blood mononuclear cells, and microbiome with non-invasive biomarkers in cancer patients
    Atsushi Mitsuhashi, Yusuke Okuma · 2018 · Clinical & Translational Oncology
  33. Biomarkers in Immunotherapy-Based Precision Treatments of Digestive System Tumors
    Zhu Zeng, Biao Yang, Zhengyin Liao · 2021 · Frontiers in Oncology
  34. Molecular testing in stage I–III non-small cell lung cancer: Approaches and challenges
    Charu Aggarwal, Lukas Bubendorf, Wendy A. Cooper, Peter Bela Illei, Paula Borralho, Boon‐Hean Ong, Ming‐Sound Tsao, Yasushi Yatabe, Keith M. Kerr · 2021 · Lung Cancer
  35. The Role of Circulating Biomarkers in Lung Cancer
    Sayuri Herath, Habib Sadeghirad, Payar Radfar, Rahul Ladwa, Majid Ebrahimi Warkiani, Kenneth John O'Byrne, Arutha Kulasinghe · 2022 · Frontiers in Oncology
  36. Genomic Profiling of Bronchoalveolar Lavage Fluid in Lung Cancer
    Viswam S. Nair, Angela Bik‐Yu Hui, Jacob J. Chabon, Mohammad Shahrokh Esfahani, Henning Stehr, Barzin Y. Nabet, Li Zhou, Aadel A. Chaudhuri, Jalen Anthony Benson, Kelsey Ayers et al. · 2022 · Cancer Research
  37. Biomarkers for early diagnosis of pancreatic cancer
    Jenkinson, Claire, Earl, Julie, Ghaneh, Paula, Halloran, Christopher, Carrato, Alfredo, Greenhalf, William, Neoptolemos, John, Costello, Eithne · 2015 · Expert Review of Gastroenterology & Hepatology
  38. A Comprehensive Circulating Tumor DNA Assay for Detection of Translocation and Copy-Number Changes in Pediatric Sarcomas
    Shah, Avanthi Tayi, Azad, Tej D., Breese, Marcus R., Chabon, Jacob J., Hamilton, Emily G., Straessler, Krystal, Kurtz, David M., Leung, Stanley G., Spillinger, Aviv, Liu, Heng-Yi et al. · 2021 · Molecular Cancer Therapeutics
  39. Accuracy of minimal residual disease detection by circulating tumor DNA profiling in lung cancer: a meta-analysis
    Ran Zhong, Rui Gao, Wenhai Fu, Caichen Li, Zhenyu Huo, Yuewen Gao, Yi Lu, Feng Li, Fan Ge, Hengjia Tu et al. · 2023 · BMC Medicine
  40. BRCA1/2 alterations and reversion mutations in the area of PARP inhibitors in high grade ovarian cancer: state of the art and forthcoming challenges
    L. Collet, Brunhilde Hanvic, Margherita Turinetto, Isabelle Treilleux, Nicolas Chopin, Olivia Le Saux, Isabelle Laure Ray-Coquard · 2024 · Frontiers in Oncology
  41. Liquid biopsies across the cancer care continuum
    Blair V. Landon, Akshaya Vijaya Annapragada, Noushin Niknafs, Victor E. Velculescu, Valsamo Anagnostou · 2025 · Nature Medicine
  42. Comparison of Genetic and Epigenetic Alterations of Primary Tumors and Matched Plasma Samples in Patients with Colorectal Cancer
    Elisa Danese, Anna Maria Minicozzi, Marco Benati, Martina Montagnana, Elisa Paviati, Gian Luca Salvagno, Gabriel Lima-Oliveira, Milena Gusella, Felice Pasini, Giuseppe Lippi et al. · 2015 · PLoS ONE
  43. The current status of the clinical utility of liquid biopsies in cancer
    Anson E. Snow, Denaly Chen, Julie E. Lang · 2019 · Expert Review of Molecular Diagnostics
  44. Clonal Hematopoiesis in Late-Stage Non–Small-Cell Lung Cancer and Its Impact on Targeted Panel Next-Generation Sequencing
    Stephanie J. Yaung, Frederike Fuhlbrück, Maureen Peterson, Wei Zou, John F. Palma, Namrata S. Patil, Yuqiu Jiang · 2020 · JCO Precision Oncology
  45. Genotyping of circulating cell-free DNA enables noninvasive tumor detection in myxoid liposarcomas
    Braig, David, Becherer, Caroline, Bickert, Christiane, Braig, Moritz, Claus, Rainer, Eisenhardt, Anja E., Heinz, Juergen, Scholber, Jutta, Herget, Georg W., Bronsert, Peter et al. · 2019 · International Journal of Cancer
  46. The promises and challenges of early non‐small cell lung cancer detection: patient perceptions, low‐dose CT screening, bronchoscopy and biomarkers
    Lukas Kalinke, Ricky M. Thakrar, Sam M. Janes · 2020 · Molecular Oncology
  47. The Role of Circulating Tumor DNA in Advanced Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
    Haowei Wang, Fei Zhou, Meng Qiao, Xuefei Li, Chao Zhao, Lei Cheng, Xiaoxia Chen, Caicun Zhou · 2021 · Frontiers in Oncology
  48. Liquid Biopsies in Lung Cancer
    Marcel Kemper, Carolin Krekeler, Kerstin Menck, Georg Lenz, Georg Evers, Arik Bernard Schulze, Annalen Bleckmann · 2023 · Cancers
  49. Entirely noninvasive outcome prediction in central nervous system lymphomas using circulating tumor DNA
    Jan‐Michel Heger, Julia Mattlener, Jessica Schneider, Philipp Gödel, Noëlle Sieg, Fabian Ullrich, Richard I. Lewis, Teodora Bucaciuc Mracica, Roland F. Schwarz, Daniel F. Ruess et al. · 2023 · Blood
  50. Defining molecular risk in ALK+ NSCLC
    Petros Christopoulos, Jan Budczies, Martina Kirchner, Steffen Dietz, Holger Sültmann, Michael Thomas, Albrecht Stenzinger · 2019 · Oncotarget
  51. Assessment of circulating copy number variant detection for cancer screening
    Bhuvan Molparia, Eshaan Nichani, Ali Torkamani · 2017 · PLoS ONE
  52. Analytical performance evaluation of a commercial next generation sequencing liquid biopsy platform using plasma ctDNA, reference standards, and synthetic serial dilution samples derived from normal plasma
    Suman Verma, Mathew W. Moore, Rebecca Ringler, Abhisek Ghosal, Kyle C. Horvath, Theodore Naef, Sheri Anvari, Philip D. Cotter, Shelly R. Gunn · 2020 · BMC Cancer
  53. Ultrasensitive circulating tumor DNA analysis enables precision medicine: experimental workflow considerations
    Daniel Andersson, Helena Kristiansson, Mikael Kubista, Anders Ståhlberg · 2021 · Expert Review of Molecular Diagnostics
  54. Exploration of resistance mechanisms for epidermal growth factor receptor‐tyrosine kinase inhibitors based on plasma analysis by digital polymerase chain reaction and next‐generation sequencing
    Eiji Iwama, Kazuko Sakai, Koichi Azuma, Daijiro Harada, Kaname Nosaki, Katsuyuki Hotta, Makoto Nishio, Takayasu Kurata, Tatsuro Fukuhara, Hiroaki Akamatsu et al. · 2018 · Cancer Science
  55. Combination bezafibrate and nivolumab treatment of patients with advanced non–small cell lung cancer
    Kentaro Tanaka, Kenji Chamoto, Sho Saeki, Ryusuke Hatae, Yuki Ikematsu, Kazuko Sakai, Nobuhisa Ando, Kazuhiro Sonomura, Shinsuke Kojima, Masanori Taketsuna et al. · 2022 · Science Translational Medicine
  56. Application of Circulating Tumor DNA as a Non-Invasive Tool for Monitoring the Progression of Colorectal Cancer
    Jiaolin Zhou, Lianpeng Chang, Yanfang Guan, Ling Yang, Xuefeng Xia, Liqiang Cui, Xin Yi, Guole Lin · 2016 · PLoS ONE
  57. Circulating tumor DNA as a liquid biopsy in plasma cell dyscrasias
    Bernhard Gerber, Martina Manzoni, Valeria Spina, Alessio Bruscaggin, Marta Lionetti, Sonia Fabris, Marzia Barbieri, Gabriella Ciceri, Alessandra Pompa, Gabriela Forestieri et al. · 2018 · Haematologica
  58. From validity to clinical utility: the influence of circulating tumor DNA on melanoma patient management in a real‐world setting
    Steven P. Rowe, Brandon S. Luber, Monique Makell, Patricia Brothers, JoAnn Santmyer, Megan Davis Schollenberger, Hannah Quinn, Daniel L. Edelstein, Frederick Scheetz Jones, Karen B. Bleich et al. · 2018 · Molecular Oncology
  59. Circulating Tumor DNA and Hepatocellular Carcinoma
    Ju Dong Yang, MC Liu, John B. Kisiel · 2019 · Seminars in Liver Disease
  60. One-step enzyme-free detection of the miRNA let-7a via twin-stage signal amplification
    Jiamei Pu, Mingbin Liu, Hongbo Li, Zhigang Liao, Weihua Zhao, Suqin Wang, Yun Zhang, Ru‐Qin Yu · 2021 · Talanta
  61. Exploring genetic alterations in circulating tumor DNA from cerebrospinal fluid of pediatric medulloblastoma
    Yanling Sun, Miao Li, Siqi Ren, Yan Liu, Jin Zhang, Shuting Li, Wenchao Gao, Xiaojun Gong, Jingjing Liu, Yuan Wang et al. · 2021 · Scientific Reports
  62. Unique Features of Hepatitis B Virus-Related Hepatocellular Carcinoma in Pathogenesis and Clinical Significance
    Sheng‐Han Wang, Shiou‐Hwei Yeh, Pei‐Jer Chen · 2021 · Cancers
  63. Radiogenomic Analysis of Locally Advanced Lung Cancer Based on CT Imaging and Intratreatment Changes in Cell-Free DNA
    Kyle Jon Lafata, Michael Nino Corradetti, Junheng Gao, Corbin D. Jacobs, Jingxi Weng, Yushi Chang, Chunhao Wang, Ace Joseph Hatch, Eric P. Xanthopoulos, Greg Jones et al. · 2021 · Radiology Imaging Cancer
  64. Sensitive detection of tumor mutations from blood and its application to immunotherapy prognosis
    Shuo Li, Zorawar Singh Noor, Weihua Zeng, Mary L. Stackpole, Xiaohui Ni, Yonggang Zhou, Zuyang Yuan, Wing Hung Wong, Vatche Garen Agopian, Steven M. Dubinett et al. · 2021 · Nature Communications
  65. Liquid Biopsy for Biomarker Testing in Non-Small Cell Lung Cancer: A European Perspective
    Umberto Malapelle, Marcello Tiseo, Ana P. Vivancos, Joshua R. Kapp, María José Serrano, Markus Tiemann · 2021 · Journal of Molecular Pathology
  66. Potential of Circulating Tumor DNA for the Management of Patients With Lymphoma
    Sarah Huet, Gilles Salles · 2020 · JCO Oncology Practice
  67. Cross-reactivity between microbial and tumor antigens
    Zitvogel, Laurence, Kroemer, Guido · 2022 · Current Opinion in Immunology
  68. Detecting liquid remnants of solid tumors treated with curative intent: Circulating tumor DNA as a biomarker of minimal residual disease (Review)
    Huijuan Chen, Qiming Zhou · 2023 · Oncology Reports
  69. Liquid biopsy: Cell-free DNA based analysis in breast cancer
    Konstantinos Venetis, Giulia Cursano, Carlo Pescia, Marianna D’Ercole, Francesca Maria Porta, Marta Cruz Blanco, Chiara Frascarelli, Mariia D. Ivanova, Elena Guerini‐Rocco, Nicola Fusco · 2023 · The Journal of Liquid Biopsy
  70. Circulating tumour DNA alterations: emerging biomarker in head and neck squamous cell carcinoma
    Xiaomin Huang, Pascal H. G. Duijf, Sharath Sriram, Ganganath S. Perera, Sarju S. Vasani, Liz Kenny, Paul Leo, Chamindie Punyadeera · 2023 · Journal of Biomedical Science
  71. Circulating tumor DNA as liquid biopsy in lung cancer: Biological characteristics and clinical integration
    Changshu Li, Jun Shao, Peiyi Li, Jiaming Feng, Jingwei Li, Chengdi Wang · 2023 · Cancer Letters
  72. Diagnostic potential of tumor DNA from ovarian cyst fluid
    Yuxuan Wang, Karin Sundfeldt, Constantina Mateoiu, Ie‐Ming Shih, Robert J. Kurman, Joy Schaefer, Natalie Silliman, Isaac Kinde, Simeon U. Springer, Michael Bonner Foote et al. · 2016 · eLife
  73. Advancing Ultrasensitive Molecular and Cellular Analysis Methods to Speed and Simplify the Diagnosis of Disease
    Shana O. Kelley · 2017 · Accounts of Chemical Research
  74. Molecular Profiling of Liquid Biopsy Samples for Precision Medicine
    Camila D. M. Campos, Joshua M. Jackson, Malgorzata Anna Witek, Steven A. Soper · 2018 · The Cancer Journal
  75. Circulating tumor DNA – Current state of play and future perspectives
    Gabriele De Rubis, Sabna Rajeev Krishnan, Mary Bebawy · 2018 · Pharmacological Research
  76. Monitoring of circulating tumor DNA and its aberrant methylation in the surveillance of surgical lung Cancer patients: protocol for a prospective observational study
    Guannan Kang, Kezhong Chen, Fan Yang, Shannon Chuai, Heng Zhao, Kai Zhang, Bingsi Li, Zhihong Zhang, Jun Wang · 2019 · BMC Cancer
  77. Comprehensive multiparameter genetic analysis improves circulating tumor DNA detection in head and neck cancer patients
    Steven W. Mes, Arjen Brink, Erik A. Sistermans, Roy Straver, Cees B.M. Oudejans, Jos B. Poell, Charles René Leemans, Ruud H. Brakenhoff · 2020 · Oral Oncology
  78. Patient specific circulating tumor DNA fingerprints to monitor treatment response across multiple tumors
    Jiaping Li, Wei Jiang, Jinwang Wei, Jianwei Zhang, Linbo Cai, Minjie Luo, Zhan Wang, Wending Sun, Shengzhou Wang, Chen Wang et al. · 2020 · Journal of Translational Medicine
  79. Network approach in liquidomics landscape
    Santini, Daniele, Botticelli, Andrea, Galvano, Antonio, Iuliani, Michele, Incorvaia, Lorena, Gristina, Valerio, Taffon, Chiara, Foderaro, Simone, Paccagnella, Elisa, Simonetti, Sonia et al. · 2023 · Journal of Experimental & Clinical Cancer Research
  80. Innovative technological advancements in laboratory medicine: Predicting the lab of the future
    S. Wilson, Shannon Steele, Khosrow Adeli · 2022 · Biotechnology & Biotechnological Equipment
  81. The current status and trends of DNA extraction
    Xiaojun Ye, Bo Lei · 2023 · BioEssays
  82. Liquid Biopsy: Current advancements in clinical practice for bladder cancer
    Felice Crocetto, Ugo Amicuzi, Michele Musone, Marco Magliocchetti, Dario Di Lieto, Simone Tammaro, Antonio Luigi Pastore, Andrea Fuschi, Roberto Falabella, Matteo Ferro et al. · 2025 · The Journal of Liquid Biopsy
  83. Improved sensitivity of circulating tumor DNA measurement using short PCR amplicons
    Rikke Fredslund Andersen, Karen‐Lise Garm Spindler, Ivan Brandslund, Anders Kristian Moeller Jakobsen, Niels Pallisgaard · 2014 · Clinica Chimica Acta
  84. Circulating free DNA in the era of precision oncology: Pre‐ and post‐analytical concerns
    Junliang Lu, Zhi‐Yong Liang · 2016 · Chronic Diseases and Translational Medicine
  85. A Model-Based Personalized Cancer Screening Strategy for Detecting Early-Stage Tumors Using Blood-Borne Biomarkers
    Sharon Seiko Hori, Amelie M. Lutz, Ramasamy Paulmurugan, Sanjiv Sam Gambhir · 2017 · Cancer Research
  86. Synthetic Circulating Cell-free DNA as Quality Control Materials for Somatic Mutation Detection in Liquid Biopsy for Cancer
    Rui Zhang, Rongxue Peng, Ziyang Li, Peng Gao, Shiyu Jia, Xin Yang, Jiansheng Ding, Yanxi Han, Jiehong Xie, Jinming Li · 2017 · Clinical Chemistry
  87. Circulating Tumor DNA Testing Opens New Perspectives in Melanoma Management
    Alessandra Sacco, Laura Forgione, Marianeve Carotenuto, Antonella De Luca, Paolo A. Ascierto, Gerardo Botti, Nicola Normanno · 2020 · Cancers
  88. Challenges in Using ctDNA to Achieve Early Detection of Cancer
    Imran S. Haque, Olivier Elemento · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
  89. Recent progress of biosensors for the detection of lung cancer markers
    Shanchuan Chen, Minghan Li, Ting Weng, Deqiang Wang, Jia Geng · 2023 · Journal of Materials Chemistry B
  90. Personalizing Surveillance in Head and Neck Cancer
    Glenn J. Hanna, Nirali M. Patel, Sara G. Tedla, Kristen L. Baugnon, Ashley H. Aiken, Nishant Agrawal · 2023 · American Society of Clinical Oncology Educational Book
  91. The next steps in next-gen sequencing of cancer genomes
    David Neil Hayes, William Y. Kim · 2015 · Journal of Clinical Investigation
  92. Prostate cancer epigenetics and its clinical implications
    Srinivasan Yegnasubramanian · 2016 · Asian Journal of Andrology
  93. Circulating tumor DNA testing in advanced non-small cell lung cancer
    Everett James Moding, Maximilian Diehn, Heather A. Wakelee · 2018 · Lung Cancer
  94. Technical considerations for circulating tumor DNA detection in oncology
    Claire Franczak, Pierre Filhine-Trésarrieu, Pauline Gilson, Jean‐Louis Merlin, Lewis Au, Alexandre Harlé · 2019 · Expert Review of Molecular Diagnostics
  95. Diagnostic and prognostic impact of cell-free DNA in human cancers: Systematic review
    Klára Červená, Pavel Vodička, Veronika Polakova Vymetalkova · 2019 · Mutation Research/Reviews in Mutation Research
  96. Liquid biopsy-based comprehensive gene mutation profiling for gynecological cancer using CAncer Personalized Profiling by deep Sequencing
    Naoyuki Iwahashi, Kazuko Sakai, Tomoko Noguchi, Tamaki Yahata, Hitomi Matsukawa, Saori Toujima, Kazuto Nishio, Kazuhiko Ino · 2019 · Scientific Reports
  97. Liquid Biopsy in Colorectal Carcinoma: Clinical Applications and Challenges
    Drahomír Kolenčík, Stephanie N. Shishido, P. Pitule, Jeremy Mason, James B. Hicks, P. Kuhn · 2020 · Cancers
  98. Next generation sequencing for liquid biopsy based testing in non-small cell lung cancer in 2021
    Pasquale Pisapia, José Luís Costa, Francesco Pepe, Gianluca Russo, Gianluca Gragnano, Alessandro Russo, Antonino Iaccarino, Diego de Miguel‐Pérez, María José Serrano, Valeria Cecilia Denninghoff et al. · 2021 · Critical Reviews in Oncology/Hematology
  99. Liquid Biomarkers for Improved Diagnosis and Classification of CNS Tumors
    Severa Bunda, Jeffrey Zuccato, Mathew Ryan Voisin, Justin Z. Wang, Farshad Nassiri, Vikas S. Patil, Sheila Mansouri, Gelareh Mohammed Zadeh · 2021 · International Journal of Molecular Sciences
  100. Detection of cryptogenic malignancies from metagenomic whole genome sequencing of body fluids
    Wei Gu, Eric Talevich, Elaine D. Hsu, Zhongxia Qi, Anatoly Urisman, Scot Federman, Allan Gopez, Shaun Arevalo, Marc Gottschall, Linda Liao et al. · 2021 · Genome Medicine